Skip to main
MRNS
MRNS logo

Marinus Pharmaceuticals (MRNS)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Marinus Pharmaceuticals (MRNS) Stock

About Marinus Pharmaceuticals (MRNS)

Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded in August 2003 and is headquartered in Radnor, PA.
Market cap$29.63M
Today's volume
Revenue (TTM)$31.47M
Avg. daily volume1.69M
EBITDA (TTM)-$122.09M
Open
Price / earnings ratio-0.22x
Today's range
Debt / equity
52 week range$0.22 - $10.5
5 year debt / equity178.95x
Beta (LTM)4.21x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio1.66x
Ex-dividend date
Next earningsMay 2, 2025
Dividend payable date

Marinus Pharmaceuticals Stock Rating

What analysts recommend for MRNS stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for MRNS stock is $29.63M

The current P/E ratio for MRNS stock is -0.22

The 52-week high for MRNS stock is $10.50. The current MRNS stock price $undefined is 100.00% below its 52-week high

The 52-week low for MRNS stock is $0.22. The current MRNS stock price $undefined has increased 100.00% from its 52-week low

No, the MRNS stock does not pay dividends to its shareholders

The target price for MRNS stock is $7.23 based on the average of what a group of analyst think MRNS stock could be worth at a future date. This is not a prediction by Public.com

How to buy MRNS stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in MRNS stock

    Navigate to the Explore page. Then, type MRNS into the search bar. When you see MRNS stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased MRNS stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Marinus Pharmaceuticals Stock Earnings

The value each MRNS share was expected to gain vs. the value that each MRNS share actually gained.

Marinus Pharmaceuticals (MRNS) reported Q3 2024 earnings per share (EPS) of -$0.42, missing estimates of -$0.41 by 2.44%. In the same quarter last year, Marinus Pharmaceuticals's earnings per share (EPS) was -$0.61. Marinus Pharmaceuticals is expected to release next earnings on 05/02/2025, with an earnings per share (EPS) estimate of -$0.35.

Buy Marinus Pharmaceuticals (MRNS) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.